Member Info for zebbo

Probably trying to get a gullible punter to follow make decisions based on his £500 bet......most if not all ignore or filter

The only thing that has materially changed since the 10p target- Quote RNS - "Demand for the Company's products remains strong and the Board does not anticipate any longer term impact over and above the approximate three month delay to the manufacturing capacity increase".
Now, does that warrant an 8.5p pence drop. Or as most believe the market has it wrong, helped by Woody et al of course

Defo a good move by Solo looking towards gas. Agree 40-60m Mkt cap re list. More similar deals to come. As I have maintained we have the very same architects that got RRE moving up. We are deploying that same model. I for one will not be selling as there is so much much more to come

We aquired Cellright in 2017 for US$30mln in a move designed to lift TRX into the for front of the growing US market for regenerative medicine and bone grafts and complements TRX's own dCELL soft tissue platform. dCell only part of the regen tissue catalogue
**There is a ton of value that is not seen by most in and out day traders. This will move higher or get taken out

Regenerative medicine is one of, if not the most, exciting advancements in modern science which has far-reaching benefits for big pharma, healthcare systems and patient outcomes.
Regenerative medicine is a ‘growth’ industry in more than one sense of the word; as a sector, it’s growing from strength to strength. In fact, last year the global regenerative medicine market was worth $28bn and it’s expected to grow to $81bn by 2023

intelligent money moving in at these bargain basement prices. IIs will get a quick return as a possible T/O looms

Time to pick some up on the cheap

up nicely, expect new highs

The IP that TRX own is worth more than the current mkt cap
Never mind FDA approval for their products
Growth - ever growing demand for our products and product expansion

Dont kid yourself TRX is extremely cheap at the mo. People who have done the research understand the value

For me the most important takeaway and a key dependency for securing a great deal future deal....
"The mines will be the eighth largest nickel mines in the world, both in the LOWEST COST QUARTILE FOR PRODUCTION ."
Being one of the lowest cost producers protects us against Nickel price downside. If it drops significantly mines get mothballed, exploration stops and the cycle starts again with commodity spikes etc etc. Being in the bottom quartile we should maintain profitability even in a depressed market

If the buyer is still buying there is no need for a TR1. Possible predator still taking lines of stock.

based on volumes today and L2 info

I did say this was heading back down to ~5p, before it moves up again

Looks like a pick up in buy trades

after a fair run. Profit is profit at the end of the day. Will watch for poss tree shake/ re entry point ~1.3 level

Dont need to be a mathematician to work out the value gap here

Think we will pull back a little here

MMs will drop this down first thing then will bounce back

JamesD, you have been making similar claims since Aug this year, Glencore being a constant. Although funding aways seems to be next week, so feels like you are having a punt on Glencore and timeline

Cannot believe that people thought OTC listing would provide any updraft